Ramanan Laxminarayan, PhD, MPH, is founder and president of One Health Trust, formerly known as the Center for Disease Dynamics, Economics & Policy (CDDEP). He is also a senior research scholar at Princeton University and an affiliate professor of global health at University of Washington.
Mass antibiotic administration to children in sub-Saharan Africa reduced mortality rates, but there was little benefit when dosing was limited to infants aged 1 to 11 months, as recommended by WHO, according to results from the AVENIR trial.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.